Summary
This study was aimed to investigate the role of the delta-opioid receptor (DOR)-β-arrestin1-Bcl-2 signal transduction pathway in the pathogenesis of ulcerative colitis (UC) and the intervention effects of oxymatrine on UC. Forty Sprague-Dawley rats were divided into normal group, model group, oxymatrine-treated group and mesalazine-treated group (n=10 each) at random. The rat UC model was established by intra-colonic injection of trinitrobenzene sulfonic acid in the model group and two treatment groups. The rats in oxymatrine-treated group were subjected to intramuscular injection of oxymatrine [63 mg/(kg·day)] for 15 days, and those in mesalazine-treated group given mesalazine solution [0.5 g/(kg·day)] by gastric lavage for the same days. Animals in normal group and model group were administered 3 mL water by gastric lavage for 15 days. On the 16th day, after fasting for 24 h, the rats were sacrificed for the removal of colon tissues. The expression levels of DOR, β-arrestin1 and Bcl-2 were determined in colon tissues by immunohistochemistry and real-time quantitative polymerase chain reaction (RT-PCR), respectively. It was found that the expression levels of DOR, β-arrestin1 and Bcl-2 protein and mRNA were significantly increased in the model group as compared with the other groups (P<0.05). They were conspicuously decreased in both mesalazine-treated and oxymatrine-treated groups in contrast to the model group (P<0.05). No statistically significant difference was noted in these indices between mesalazine- and oxymatrinetreated groups (P>0.05). This study indicated that the DOR-β-arrestin1-Bcl-2 signal transduction pathway may participate in the pathogenesis of UC. Moreover, oxymatrine can attenuate the development of UC by regulating the DOR-β-arrestin1-Bcl-2 signal transduction pathway.
Similar content being viewed by others
References
Monteleone G, Caprioli F. T-cell-directed therapies in inflammatory bowel diseases. Clin Sci (Lond), 2010, 118(12):707–715
Atreya R, Neurath MF. New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol, 2008, 1(3):175–182
Sturm A, de Souza HS, Fiocchi C. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. Curr Drug Targets, 2008, 9(5):381–387
Itoh J, de La Motte C, Strong SA, et al. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn’s disease. Gut, 2001, 49(1):35–41
Bidere N, Su HC, Lenardo MJ. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol, 2006, 24:321–352
Hughes P, Bouillet P, Strasser A. Role of Bim and other Bcl-2 family members In autoimmune and degenerative diseases. Curr Dir Autoimmun, 2006, 9:74–94
Fan H, Liao Y, Tang Q. Role of β2-adrenoceptor-β-arrestin2-nuclear factor-κB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis. Chin J Integr Med (Chinese), 2012, 18(7):514–521
Fan H, Chen R, Shen L, et al. Oxymatrine improves TNBS induced colitis in rats by inhibiting the expression of NF-κBp65. J Huazhong Univ Sci Technolog Med Sci, 2008, 28(4):415–420
Zheng P, Niu FL, Liu WZ, et al. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodiurn-induced colitis of rats. World J Gastroenterol, 2005, 11(31):4912–4915
Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 1989, 96(3):795–803
Fujino K, Takami Y, de la Fuente SG, et al. Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis. J Gastrointest Surg, 2004, 8(7):842–847
González R, Rodríguez S, Romay C. Anti-inflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats. Parmacol Res, 1999, 39(1):55–59
Doering J, Begue B, Lentze MJ, et al. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn’s disease. Gut, 2004, 53(11):1632–1638
Sturm A, Leite AZ, Danese S, et al. Divergent cell cyclekinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis. Gut, 2004, 53(11):1624–1631
Peppelenbosch MP, van Deventer SJ. T cell apoptosis and inflammatory bowel disease. Gut, 2004, 53(11): 1556–1558
Hildeman DA, Zhu Y, Mitchell TC, et al. Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim. Immunity, 2002, 16(6):759–767
Veis DJ, Sorenson CM, Shutter JR, et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycysticki dneys, and hypopigmented hair. Cell, 1993, 75(2): 229–240
Shi Y, Feng Y, Kang J, et al. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol, 2007, 8(8):817–824
Shenoy SK, Lefkowitz RJ. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signaling. Biochem J, 2003, 375(Pt 3):503–515
Revankar CM, Vines CM, Cimino DF, et al. Arrestins block G protein-coupled receptor-mediated apoptosis. J Biol Chem, 2004, 279(23):24578–24584
Feng Y, He X, Yang Y, et al. Current research on opioid receptor function. Curr Drug Targets, 2012, 13(2):230–46.
Pol O, Palacio JR, Puig MM. The expression of δ-and κ-opioid receptor is enhanced during intestinal inflammation in mice. J Pharmacol Exp Ther, 2003, 306(2):455–462
Lv JF, Fan H, Shen L, et al. Effects of oxymatrine injection on expression of cytokines and nuclear factor-κB p65 in colonic intestinal mucosa of rats with experimental colitis. World J Gastroenterol, 2008, 16(20):896–899
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors contributed equally to this work.
This project was supported by grants from the National Nature Science Foundation of China (No. 81072944, and No. 81273908), Nature Science Foundation of Hubei Province of China (No. 2011CDB379), Postdoctoral Science Foundation of China (No. 2012M510120), and Doctor Fund Project of Higher Education of Ministry of Education of China (No. 20110142120096).
Rights and permissions
About this article
Cite this article
Zhou, Pq., Fan, H., Hu, H. et al. Role of DOR-β-arrestin1-Bcl2 signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 34, 815–820 (2014). https://doi.org/10.1007/s11596-014-1358-1
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-014-1358-1